nodes	percent_of_prediction	percent_of_DWPC	metapath
Dantrolene—RYR3—diaphragm—stomach cancer	0.216	0.655	CbGeAlD
Dantrolene—RYR3—hematopoietic system—stomach cancer	0.0225	0.0684	CbGeAlD
Dantrolene—RYR3—smooth muscle tissue—stomach cancer	0.0198	0.0602	CbGeAlD
Dantrolene—RYR3—Stimuli-sensing channels—CLCN3—stomach cancer	0.0171	0.104	CbGpPWpGaD
Dantrolene—RYR3—lymphoid tissue—stomach cancer	0.0158	0.0481	CbGeAlD
Dantrolene—RYR3—digestive system—stomach cancer	0.0156	0.0476	CbGeAlD
Dantrolene—RYR1—smooth muscle tissue—stomach cancer	0.0142	0.0432	CbGeAlD
Dantrolene—RYR1—Stimuli-sensing channels—CLCN3—stomach cancer	0.0126	0.0766	CbGpPWpGaD
Dantrolene—RYR3—Ion channel transport—CLCN3—stomach cancer	0.0112	0.0678	CbGpPWpGaD
Dantrolene—RYR1—endocrine gland—stomach cancer	0.00927	0.0282	CbGeAlD
Dantrolene—RYR3—Alzheimers Disease—BID—stomach cancer	0.00838	0.0507	CbGpPWpGaD
Dantrolene—RYR1—liver—stomach cancer	0.00836	0.0254	CbGeAlD
Dantrolene—RYR3—MFAP5-mediated ovarian cancer cell motility and invasiveness—JUN—stomach cancer	0.00834	0.0505	CbGpPWpGaD
Dantrolene—RYR1—Ion channel transport—CLCN3—stomach cancer	0.00825	0.0499	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—ACTC1—stomach cancer	0.00666	0.0403	CbGpPWpGaD
Dantrolene—RYR3—MFAP5-mediated ovarian cancer cell motility and invasiveness—MAPK1—stomach cancer	0.00656	0.0397	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—ACTC1—stomach cancer	0.00491	0.0297	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—RGS2—stomach cancer	0.00448	0.0271	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—RGS2—stomach cancer	0.00434	0.0263	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.00389	0.0236	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—IGFBP3—stomach cancer	0.00341	0.0206	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—RGS2—stomach cancer	0.0033	0.02	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—RGS2—stomach cancer	0.0032	0.0194	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—ADRB1—stomach cancer	0.00306	0.0185	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.00287	0.0174	CbGpPWpGaD
Dantrolene—CYP3A4—hematopoietic system—stomach cancer	0.00281	0.00853	CbGeAlD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—IGFBP3—stomach cancer	0.00251	0.0152	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—CASP8—stomach cancer	0.00251	0.0152	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—ADRB2—stomach cancer	0.00248	0.015	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—ADRB1—stomach cancer	0.00225	0.0136	CbGpPWpGaD
Dantrolene—CYP3A4—digestive system—stomach cancer	0.00195	0.00593	CbGeAlD
Dantrolene—RYR3—Alzheimers Disease—IL1B—stomach cancer	0.00191	0.0115	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—ADRB2—stomach cancer	0.00183	0.0111	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—PRKCB—stomach cancer	0.0017	0.0103	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.0017	0.0103	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—PRKCB—stomach cancer	0.00164	0.00995	CbGpPWpGaD
Dantrolene—CYP3A4—endocrine gland—stomach cancer	0.00161	0.0049	CbGeAlD
Dantrolene—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—stomach cancer	0.00159	0.00964	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—MAPK3—stomach cancer	0.00153	0.00924	CbGpPWpGaD
Dantrolene—CYP3A4—liver—stomach cancer	0.00145	0.00442	CbGeAlD
Dantrolene—RYR3—Alzheimers Disease—MAPK1—stomach cancer	0.00145	0.00879	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—TNF—stomach cancer	0.00138	0.00837	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—NOS3—stomach cancer	0.00131	0.00791	CbGpPWpGaD
Dantrolene—CYP3A4—Aflatoxin B1 metabolism—GSTM1—stomach cancer	0.00129	0.00781	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—PRKCB—stomach cancer	0.00125	0.00757	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.00125	0.00757	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—TP53—stomach cancer	0.00122	0.00738	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—PRKCB—stomach cancer	0.00121	0.00734	CbGpPWpGaD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—stomach cancer	0.0012	0.00728	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—IL1B—stomach cancer	0.00111	0.00673	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—JUN—stomach cancer	0.00108	0.00652	CbGpPWpGaD
Dantrolene—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—stomach cancer	0.00103	0.00626	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—NOS3—stomach cancer	0.000963	0.00583	CbGpPWpGaD
Dantrolene—CYP3A4—Xenobiotics—CYP2A6—stomach cancer	0.000864	0.00523	CbGpPWpGaD
Dantrolene—CYP3A4—Tamoxifen metabolism—CYP2A6—stomach cancer	0.000831	0.00503	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—IL1B—stomach cancer	0.000819	0.00496	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—JUN—stomach cancer	0.000794	0.00481	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—HMOX1—stomach cancer	0.000764	0.00463	CbGpPWpGaD
Dantrolene—CYP3A4—Tryptophan metabolism—ECHS1—stomach cancer	0.000681	0.00412	CbGpPWpGaD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—stomach cancer	0.000675	0.00409	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—IL6—stomach cancer	0.000651	0.00394	CbGpPWpGaD
Dantrolene—Anaemia—Docetaxel—stomach cancer	0.000636	0.00126	CcSEcCtD
Dantrolene—Drowsiness—Methotrexate—stomach cancer	0.000634	0.00125	CcSEcCtD
Dantrolene—Depression—Methotrexate—stomach cancer	0.000632	0.00125	CcSEcCtD
Dantrolene—Muscular weakness—Doxorubicin—stomach cancer	0.000628	0.00124	CcSEcCtD
Dantrolene—Vision blurred—Capecitabine—stomach cancer	0.000627	0.00124	CcSEcCtD
Dantrolene—Renal failure—Methotrexate—stomach cancer	0.000623	0.00123	CcSEcCtD
Dantrolene—Ill-defined disorder—Capecitabine—stomach cancer	0.000618	0.00122	CcSEcCtD
Dantrolene—Urticaria—Fluorouracil—stomach cancer	0.000618	0.00122	CcSEcCtD
Dantrolene—Dysphagia—Doxorubicin—stomach cancer	0.000616	0.00122	CcSEcCtD
Dantrolene—Leukopenia—Docetaxel—stomach cancer	0.000616	0.00122	CcSEcCtD
Dantrolene—Anaemia—Capecitabine—stomach cancer	0.000615	0.00122	CcSEcCtD
Dantrolene—Pollakiuria—Epirubicin—stomach cancer	0.000615	0.00122	CcSEcCtD
Dantrolene—Body temperature increased—Fluorouracil—stomach cancer	0.000615	0.00122	CcSEcCtD
Dantrolene—Eosinophilia—Doxorubicin—stomach cancer	0.00061	0.00121	CcSEcCtD
Dantrolene—Sweating—Methotrexate—stomach cancer	0.000608	0.0012	CcSEcCtD
Dantrolene—CYP3A4—Estrogen metabolism—GSTM1—stomach cancer	0.000606	0.00367	CbGpPWpGaD
Dantrolene—Haematuria—Methotrexate—stomach cancer	0.000605	0.0012	CcSEcCtD
Dantrolene—Malaise—Capecitabine—stomach cancer	0.0006	0.00119	CcSEcCtD
Dantrolene—Hypersensitivity—Irinotecan—stomach cancer	0.000598	0.00118	CcSEcCtD
Dantrolene—Leukopenia—Capecitabine—stomach cancer	0.000596	0.00118	CcSEcCtD
Dantrolene—Convulsion—Docetaxel—stomach cancer	0.000596	0.00118	CcSEcCtD
Dantrolene—Hypertension—Docetaxel—stomach cancer	0.000594	0.00117	CcSEcCtD
Dantrolene—Drowsiness—Epirubicin—stomach cancer	0.000593	0.00117	CcSEcCtD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—stomach cancer	0.000593	0.00359	CbGpPWpGaD
Dantrolene—Myalgia—Docetaxel—stomach cancer	0.000585	0.00116	CcSEcCtD
Dantrolene—Renal failure—Epirubicin—stomach cancer	0.000583	0.00115	CcSEcCtD
Dantrolene—Asthenia—Irinotecan—stomach cancer	0.000582	0.00115	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—APOA1—stomach cancer	0.000579	0.00351	CbGpPWpGaD
Dantrolene—Hypertension—Capecitabine—stomach cancer	0.000575	0.00114	CcSEcCtD
Dantrolene—Hypersensitivity—Fluorouracil—stomach cancer	0.000573	0.00113	CcSEcCtD
Dantrolene—Dry mouth—Docetaxel—stomach cancer	0.000573	0.00113	CcSEcCtD
Dantrolene—Haemoglobin—Methotrexate—stomach cancer	0.000572	0.00113	CcSEcCtD
Dantrolene—Haemorrhage—Methotrexate—stomach cancer	0.000569	0.00113	CcSEcCtD
Dantrolene—Hepatitis—Methotrexate—stomach cancer	0.000569	0.00113	CcSEcCtD
Dantrolene—Sweating—Epirubicin—stomach cancer	0.000569	0.00112	CcSEcCtD
Dantrolene—Pollakiuria—Doxorubicin—stomach cancer	0.000569	0.00112	CcSEcCtD
Dantrolene—Myalgia—Capecitabine—stomach cancer	0.000567	0.00112	CcSEcCtD
Dantrolene—Haematuria—Epirubicin—stomach cancer	0.000566	0.00112	CcSEcCtD
Dantrolene—Confusional state—Docetaxel—stomach cancer	0.000566	0.00112	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—HMOX1—stomach cancer	0.000563	0.00341	CbGpPWpGaD
Dantrolene—Anaphylactic shock—Docetaxel—stomach cancer	0.000561	0.00111	CcSEcCtD
Dantrolene—Discomfort—Capecitabine—stomach cancer	0.00056	0.00111	CcSEcCtD
Dantrolene—Diarrhoea—Irinotecan—stomach cancer	0.000555	0.0011	CcSEcCtD
Dantrolene—Dry mouth—Capecitabine—stomach cancer	0.000554	0.0011	CcSEcCtD
Dantrolene—CYP3A4—Irinotecan Pathway—APC—stomach cancer	0.00055	0.00333	CbGpPWpGaD
Dantrolene—Pruritus—Fluorouracil—stomach cancer	0.00055	0.00109	CcSEcCtD
Dantrolene—Thrombocytopenia—Docetaxel—stomach cancer	0.000549	0.00109	CcSEcCtD
Dantrolene—Drowsiness—Doxorubicin—stomach cancer	0.000549	0.00109	CcSEcCtD
Dantrolene—Visual impairment—Methotrexate—stomach cancer	0.000549	0.00108	CcSEcCtD
Dantrolene—Confusional state—Capecitabine—stomach cancer	0.000548	0.00108	CcSEcCtD
Dantrolene—Tachycardia—Docetaxel—stomach cancer	0.000548	0.00108	CcSEcCtD
Dantrolene—Renal failure—Doxorubicin—stomach cancer	0.00054	0.00107	CcSEcCtD
Dantrolene—Dizziness—Irinotecan—stomach cancer	0.000537	0.00106	CcSEcCtD
Dantrolene—Haemoglobin—Epirubicin—stomach cancer	0.000535	0.00106	CcSEcCtD
Dantrolene—Anorexia—Docetaxel—stomach cancer	0.000535	0.00106	CcSEcCtD
Dantrolene—Haemorrhage—Epirubicin—stomach cancer	0.000533	0.00105	CcSEcCtD
Dantrolene—Hepatitis—Epirubicin—stomach cancer	0.000533	0.00105	CcSEcCtD
Dantrolene—Diarrhoea—Fluorouracil—stomach cancer	0.000532	0.00105	CcSEcCtD
Dantrolene—Thrombocytopenia—Capecitabine—stomach cancer	0.000532	0.00105	CcSEcCtD
Dantrolene—Tachycardia—Capecitabine—stomach cancer	0.00053	0.00105	CcSEcCtD
Dantrolene—Sweating—Doxorubicin—stomach cancer	0.000526	0.00104	CcSEcCtD
Dantrolene—Hyperhidrosis—Capecitabine—stomach cancer	0.000525	0.00104	CcSEcCtD
Dantrolene—Haematuria—Doxorubicin—stomach cancer	0.000524	0.00104	CcSEcCtD
Dantrolene—Anorexia—Capecitabine—stomach cancer	0.000518	0.00102	CcSEcCtD
Dantrolene—Vomiting—Irinotecan—stomach cancer	0.000516	0.00102	CcSEcCtD
Dantrolene—Dizziness—Fluorouracil—stomach cancer	0.000514	0.00102	CcSEcCtD
Dantrolene—Visual impairment—Epirubicin—stomach cancer	0.000513	0.00101	CcSEcCtD
Dantrolene—Rash—Irinotecan—stomach cancer	0.000512	0.00101	CcSEcCtD
Dantrolene—Dermatitis—Irinotecan—stomach cancer	0.000511	0.00101	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000511	0.00101	CcSEcCtD
Dantrolene—Chills—Methotrexate—stomach cancer	0.000511	0.00101	CcSEcCtD
Dantrolene—Headache—Irinotecan—stomach cancer	0.000509	0.00101	CcSEcCtD
Dantrolene—Insomnia—Docetaxel—stomach cancer	0.000508	0.001	CcSEcCtD
Dantrolene—Somnolence—Docetaxel—stomach cancer	0.000499	0.000986	CcSEcCtD
Dantrolene—Erythema—Methotrexate—stomach cancer	0.000496	0.00098	CcSEcCtD
Dantrolene—Haemoglobin—Doxorubicin—stomach cancer	0.000495	0.000979	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000495	0.000979	CcSEcCtD
Dantrolene—Flushing—Epirubicin—stomach cancer	0.000494	0.000977	CcSEcCtD
Dantrolene—Vomiting—Fluorouracil—stomach cancer	0.000494	0.000977	CcSEcCtD
Dantrolene—Dyspepsia—Docetaxel—stomach cancer	0.000494	0.000977	CcSEcCtD
Dantrolene—Haemorrhage—Doxorubicin—stomach cancer	0.000493	0.000975	CcSEcCtD
Dantrolene—Hepatitis—Doxorubicin—stomach cancer	0.000493	0.000975	CcSEcCtD
Dantrolene—Insomnia—Capecitabine—stomach cancer	0.000491	0.000971	CcSEcCtD
Dantrolene—Rash—Fluorouracil—stomach cancer	0.00049	0.000969	CcSEcCtD
Dantrolene—Dermatitis—Fluorouracil—stomach cancer	0.00049	0.000968	CcSEcCtD
Dantrolene—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—stomach cancer	0.000488	0.00295	CbGpPWpGaD
Dantrolene—Decreased appetite—Docetaxel—stomach cancer	0.000488	0.000964	CcSEcCtD
Dantrolene—Headache—Fluorouracil—stomach cancer	0.000487	0.000963	CcSEcCtD
Dantrolene—Dysgeusia—Methotrexate—stomach cancer	0.000485	0.000959	CcSEcCtD
Dantrolene—Fatigue—Docetaxel—stomach cancer	0.000484	0.000956	CcSEcCtD
Dantrolene—Nausea—Irinotecan—stomach cancer	0.000482	0.000953	CcSEcCtD
Dantrolene—Constipation—Docetaxel—stomach cancer	0.00048	0.000949	CcSEcCtD
Dantrolene—Pain—Docetaxel—stomach cancer	0.00048	0.000949	CcSEcCtD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—IL6—stomach cancer	0.00048	0.00291	CbGpPWpGaD
Dantrolene—Back pain—Methotrexate—stomach cancer	0.000479	0.000948	CcSEcCtD
Dantrolene—Dyspepsia—Capecitabine—stomach cancer	0.000478	0.000945	CcSEcCtD
Dantrolene—Chills—Epirubicin—stomach cancer	0.000478	0.000945	CcSEcCtD
Dantrolene—Visual impairment—Doxorubicin—stomach cancer	0.000475	0.000939	CcSEcCtD
Dantrolene—Decreased appetite—Capecitabine—stomach cancer	0.000472	0.000934	CcSEcCtD
Dantrolene—Fatigue—Capecitabine—stomach cancer	0.000468	0.000926	CcSEcCtD
Dantrolene—Vision blurred—Methotrexate—stomach cancer	0.000467	0.000923	CcSEcCtD
Dantrolene—Constipation—Capecitabine—stomach cancer	0.000465	0.000919	CcSEcCtD
Dantrolene—Pain—Capecitabine—stomach cancer	0.000465	0.000919	CcSEcCtD
Dantrolene—Erythema—Epirubicin—stomach cancer	0.000464	0.000917	CcSEcCtD
Dantrolene—Feeling abnormal—Docetaxel—stomach cancer	0.000462	0.000914	CcSEcCtD
Dantrolene—Nausea—Fluorouracil—stomach cancer	0.000462	0.000913	CcSEcCtD
Dantrolene—Ill-defined disorder—Methotrexate—stomach cancer	0.00046	0.000909	CcSEcCtD
Dantrolene—Gastrointestinal pain—Docetaxel—stomach cancer	0.000459	0.000907	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—ALB—stomach cancer	0.000459	0.00278	CbGpPWpGaD
Dantrolene—Anaemia—Methotrexate—stomach cancer	0.000458	0.000906	CcSEcCtD
Dantrolene—Flushing—Doxorubicin—stomach cancer	0.000458	0.000904	CcSEcCtD
Dantrolene—Tension—Epirubicin—stomach cancer	0.000455	0.0009	CcSEcCtD
Dantrolene—Dysgeusia—Epirubicin—stomach cancer	0.000454	0.000898	CcSEcCtD
Dantrolene—Nervousness—Epirubicin—stomach cancer	0.00045	0.00089	CcSEcCtD
Dantrolene—Back pain—Epirubicin—stomach cancer	0.000449	0.000887	CcSEcCtD
Dantrolene—Feeling abnormal—Capecitabine—stomach cancer	0.000448	0.000885	CcSEcCtD
Dantrolene—Malaise—Methotrexate—stomach cancer	0.000447	0.000884	CcSEcCtD
Dantrolene—Gastrointestinal pain—Capecitabine—stomach cancer	0.000444	0.000878	CcSEcCtD
Dantrolene—Body temperature increased—Docetaxel—stomach cancer	0.000444	0.000877	CcSEcCtD
Dantrolene—Abdominal pain—Docetaxel—stomach cancer	0.000444	0.000877	CcSEcCtD
Dantrolene—Leukopenia—Methotrexate—stomach cancer	0.000444	0.000877	CcSEcCtD
Dantrolene—Chills—Doxorubicin—stomach cancer	0.000442	0.000874	CcSEcCtD
Dantrolene—Vision blurred—Epirubicin—stomach cancer	0.000437	0.000864	CcSEcCtD
Dantrolene—Urticaria—Capecitabine—stomach cancer	0.000432	0.000853	CcSEcCtD
Dantrolene—Ill-defined disorder—Epirubicin—stomach cancer	0.00043	0.000851	CcSEcCtD
Dantrolene—Body temperature increased—Capecitabine—stomach cancer	0.00043	0.000849	CcSEcCtD
Dantrolene—Abdominal pain—Capecitabine—stomach cancer	0.00043	0.000849	CcSEcCtD
Dantrolene—Convulsion—Methotrexate—stomach cancer	0.000429	0.000849	CcSEcCtD
Dantrolene—Erythema—Doxorubicin—stomach cancer	0.000429	0.000848	CcSEcCtD
Dantrolene—Anaemia—Epirubicin—stomach cancer	0.000429	0.000847	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—APOA1—stomach cancer	0.000427	0.00258	CbGpPWpGaD
Dantrolene—Myalgia—Methotrexate—stomach cancer	0.000422	0.000834	CcSEcCtD
Dantrolene—Tension—Doxorubicin—stomach cancer	0.000421	0.000832	CcSEcCtD
Dantrolene—Dysgeusia—Doxorubicin—stomach cancer	0.00042	0.000831	CcSEcCtD
Dantrolene—Malaise—Epirubicin—stomach cancer	0.000418	0.000827	CcSEcCtD
Dantrolene—Discomfort—Methotrexate—stomach cancer	0.000417	0.000824	CcSEcCtD
Dantrolene—Nervousness—Doxorubicin—stomach cancer	0.000417	0.000824	CcSEcCtD
Dantrolene—Leukopenia—Epirubicin—stomach cancer	0.000415	0.000821	CcSEcCtD
Dantrolene—Back pain—Doxorubicin—stomach cancer	0.000415	0.000821	CcSEcCtD
Dantrolene—Hypersensitivity—Docetaxel—stomach cancer	0.000413	0.000817	CcSEcCtD
Dantrolene—Confusional state—Methotrexate—stomach cancer	0.000408	0.000806	CcSEcCtD
Dantrolene—Anaphylactic shock—Methotrexate—stomach cancer	0.000404	0.0008	CcSEcCtD
Dantrolene—Vision blurred—Doxorubicin—stomach cancer	0.000404	0.0008	CcSEcCtD
Dantrolene—Asthenia—Docetaxel—stomach cancer	0.000403	0.000796	CcSEcCtD
Dantrolene—Convulsion—Epirubicin—stomach cancer	0.000402	0.000794	CcSEcCtD
Dantrolene—Hypertension—Epirubicin—stomach cancer	0.0004	0.000792	CcSEcCtD
Dantrolene—Hypersensitivity—Capecitabine—stomach cancer	0.0004	0.000791	CcSEcCtD
Dantrolene—Ill-defined disorder—Doxorubicin—stomach cancer	0.000398	0.000787	CcSEcCtD
Dantrolene—Pruritus—Docetaxel—stomach cancer	0.000397	0.000785	CcSEcCtD
Dantrolene—Anaemia—Doxorubicin—stomach cancer	0.000397	0.000784	CcSEcCtD
Dantrolene—Thrombocytopenia—Methotrexate—stomach cancer	0.000396	0.000783	CcSEcCtD
Dantrolene—Myalgia—Epirubicin—stomach cancer	0.000395	0.000781	CcSEcCtD
Dantrolene—Hyperhidrosis—Methotrexate—stomach cancer	0.000391	0.000773	CcSEcCtD
Dantrolene—Discomfort—Epirubicin—stomach cancer	0.00039	0.000771	CcSEcCtD
Dantrolene—Asthenia—Capecitabine—stomach cancer	0.00039	0.000771	CcSEcCtD
Dantrolene—Malaise—Doxorubicin—stomach cancer	0.000387	0.000765	CcSEcCtD
Dantrolene—Dry mouth—Epirubicin—stomach cancer	0.000386	0.000763	CcSEcCtD
Dantrolene—Anorexia—Methotrexate—stomach cancer	0.000386	0.000762	CcSEcCtD
Dantrolene—Pruritus—Capecitabine—stomach cancer	0.000384	0.00076	CcSEcCtD
Dantrolene—Leukopenia—Doxorubicin—stomach cancer	0.000384	0.000759	CcSEcCtD
Dantrolene—Diarrhoea—Docetaxel—stomach cancer	0.000384	0.000759	CcSEcCtD
Dantrolene—Confusional state—Epirubicin—stomach cancer	0.000382	0.000754	CcSEcCtD
Dantrolene—Anaphylactic shock—Epirubicin—stomach cancer	0.000379	0.000748	CcSEcCtD
Dantrolene—Convulsion—Doxorubicin—stomach cancer	0.000372	0.000735	CcSEcCtD
Dantrolene—Diarrhoea—Capecitabine—stomach cancer	0.000372	0.000735	CcSEcCtD
Dantrolene—Dizziness—Docetaxel—stomach cancer	0.000371	0.000734	CcSEcCtD
Dantrolene—Thrombocytopenia—Epirubicin—stomach cancer	0.000371	0.000733	CcSEcCtD
Dantrolene—Hypertension—Doxorubicin—stomach cancer	0.000371	0.000732	CcSEcCtD
Dantrolene—Tachycardia—Epirubicin—stomach cancer	0.000369	0.00073	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000369	0.000728	CcSEcCtD
Dantrolene—Hyperhidrosis—Epirubicin—stomach cancer	0.000366	0.000723	CcSEcCtD
Dantrolene—Insomnia—Methotrexate—stomach cancer	0.000366	0.000723	CcSEcCtD
Dantrolene—Myalgia—Doxorubicin—stomach cancer	0.000365	0.000722	CcSEcCtD
Dantrolene—Discomfort—Doxorubicin—stomach cancer	0.000361	0.000714	CcSEcCtD
Dantrolene—Anorexia—Epirubicin—stomach cancer	0.000361	0.000713	CcSEcCtD
Dantrolene—Somnolence—Methotrexate—stomach cancer	0.00036	0.000711	CcSEcCtD
Dantrolene—Dizziness—Capecitabine—stomach cancer	0.000359	0.00071	CcSEcCtD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	0.000359	0.00217	CbGpPWpGaD
Dantrolene—Dry mouth—Doxorubicin—stomach cancer	0.000357	0.000706	CcSEcCtD
Dantrolene—Vomiting—Docetaxel—stomach cancer	0.000357	0.000705	CcSEcCtD
Dantrolene—Dyspepsia—Methotrexate—stomach cancer	0.000356	0.000704	CcSEcCtD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	0.000354	0.00214	CbGpPWpGaD
Dantrolene—Rash—Docetaxel—stomach cancer	0.000354	0.000699	CcSEcCtD
Dantrolene—Dermatitis—Docetaxel—stomach cancer	0.000354	0.000699	CcSEcCtD
Dantrolene—Confusional state—Doxorubicin—stomach cancer	0.000353	0.000698	CcSEcCtD
Dantrolene—Decreased appetite—Methotrexate—stomach cancer	0.000352	0.000695	CcSEcCtD
Dantrolene—Headache—Docetaxel—stomach cancer	0.000352	0.000695	CcSEcCtD
Dantrolene—Anaphylactic shock—Doxorubicin—stomach cancer	0.00035	0.000692	CcSEcCtD
Dantrolene—Fatigue—Methotrexate—stomach cancer	0.000349	0.000689	CcSEcCtD
Dantrolene—Pain—Methotrexate—stomach cancer	0.000346	0.000684	CcSEcCtD
Dantrolene—Vomiting—Capecitabine—stomach cancer	0.000345	0.000683	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000345	0.000682	CcSEcCtD
Dantrolene—Thrombocytopenia—Doxorubicin—stomach cancer	0.000343	0.000678	CcSEcCtD
Dantrolene—Rash—Capecitabine—stomach cancer	0.000343	0.000677	CcSEcCtD
Dantrolene—Insomnia—Epirubicin—stomach cancer	0.000342	0.000677	CcSEcCtD
Dantrolene—Dermatitis—Capecitabine—stomach cancer	0.000342	0.000677	CcSEcCtD
Dantrolene—Tachycardia—Doxorubicin—stomach cancer	0.000342	0.000676	CcSEcCtD
Dantrolene—Headache—Capecitabine—stomach cancer	0.00034	0.000673	CcSEcCtD
Dantrolene—Hyperhidrosis—Doxorubicin—stomach cancer	0.000339	0.000669	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—ALB—stomach cancer	0.000338	0.00205	CbGpPWpGaD
Dantrolene—Somnolence—Epirubicin—stomach cancer	0.000337	0.000665	CcSEcCtD
Dantrolene—Anorexia—Doxorubicin—stomach cancer	0.000334	0.00066	CcSEcCtD
Dantrolene—Nausea—Docetaxel—stomach cancer	0.000333	0.000659	CcSEcCtD
Dantrolene—Feeling abnormal—Methotrexate—stomach cancer	0.000333	0.000659	CcSEcCtD
Dantrolene—Dyspepsia—Epirubicin—stomach cancer	0.000333	0.000659	CcSEcCtD
Dantrolene—Gastrointestinal pain—Methotrexate—stomach cancer	0.000331	0.000654	CcSEcCtD
Dantrolene—Decreased appetite—Epirubicin—stomach cancer	0.000329	0.00065	CcSEcCtD
Dantrolene—Fatigue—Epirubicin—stomach cancer	0.000326	0.000645	CcSEcCtD
Dantrolene—Pain—Epirubicin—stomach cancer	0.000324	0.00064	CcSEcCtD
Dantrolene—Constipation—Epirubicin—stomach cancer	0.000324	0.00064	CcSEcCtD
Dantrolene—Nausea—Capecitabine—stomach cancer	0.000323	0.000638	CcSEcCtD
Dantrolene—Urticaria—Methotrexate—stomach cancer	0.000321	0.000635	CcSEcCtD
Dantrolene—Abdominal pain—Methotrexate—stomach cancer	0.00032	0.000632	CcSEcCtD
Dantrolene—Body temperature increased—Methotrexate—stomach cancer	0.00032	0.000632	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000319	0.000631	CcSEcCtD
Dantrolene—Insomnia—Doxorubicin—stomach cancer	0.000317	0.000626	CcSEcCtD
Dantrolene—Feeling abnormal—Epirubicin—stomach cancer	0.000312	0.000617	CcSEcCtD
Dantrolene—Somnolence—Doxorubicin—stomach cancer	0.000311	0.000616	CcSEcCtD
Dantrolene—Gastrointestinal pain—Epirubicin—stomach cancer	0.00031	0.000612	CcSEcCtD
Dantrolene—Dyspepsia—Doxorubicin—stomach cancer	0.000308	0.000609	CcSEcCtD
Dantrolene—Decreased appetite—Doxorubicin—stomach cancer	0.000304	0.000602	CcSEcCtD
Dantrolene—Fatigue—Doxorubicin—stomach cancer	0.000302	0.000597	CcSEcCtD
Dantrolene—Urticaria—Epirubicin—stomach cancer	0.000301	0.000594	CcSEcCtD
Dantrolene—Pain—Doxorubicin—stomach cancer	0.0003	0.000592	CcSEcCtD
Dantrolene—Constipation—Doxorubicin—stomach cancer	0.0003	0.000592	CcSEcCtD
Dantrolene—Body temperature increased—Epirubicin—stomach cancer	0.000299	0.000592	CcSEcCtD
Dantrolene—Abdominal pain—Epirubicin—stomach cancer	0.000299	0.000592	CcSEcCtD
Dantrolene—Hypersensitivity—Methotrexate—stomach cancer	0.000298	0.000589	CcSEcCtD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	0.000291	0.00176	CbGpPWpGaD
Dantrolene—Asthenia—Methotrexate—stomach cancer	0.00029	0.000574	CcSEcCtD
Dantrolene—Feeling abnormal—Doxorubicin—stomach cancer	0.000289	0.000571	CcSEcCtD
Dantrolene—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000286	0.000566	CcSEcCtD
Dantrolene—Pruritus—Methotrexate—stomach cancer	0.000286	0.000566	CcSEcCtD
Dantrolene—Hypersensitivity—Epirubicin—stomach cancer	0.000279	0.000551	CcSEcCtD
Dantrolene—Urticaria—Doxorubicin—stomach cancer	0.000278	0.00055	CcSEcCtD
Dantrolene—Abdominal pain—Doxorubicin—stomach cancer	0.000277	0.000547	CcSEcCtD
Dantrolene—Body temperature increased—Doxorubicin—stomach cancer	0.000277	0.000547	CcSEcCtD
Dantrolene—Diarrhoea—Methotrexate—stomach cancer	0.000277	0.000547	CcSEcCtD
Dantrolene—Asthenia—Epirubicin—stomach cancer	0.000272	0.000537	CcSEcCtD
Dantrolene—Pruritus—Epirubicin—stomach cancer	0.000268	0.000529	CcSEcCtD
Dantrolene—Dizziness—Methotrexate—stomach cancer	0.000267	0.000529	CcSEcCtD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.000261	0.00158	CbGpPWpGaD
Dantrolene—Diarrhoea—Epirubicin—stomach cancer	0.000259	0.000512	CcSEcCtD
Dantrolene—Hypersensitivity—Doxorubicin—stomach cancer	0.000258	0.00051	CcSEcCtD
Dantrolene—Vomiting—Methotrexate—stomach cancer	0.000257	0.000508	CcSEcCtD
Dantrolene—Rash—Methotrexate—stomach cancer	0.000255	0.000504	CcSEcCtD
Dantrolene—Dermatitis—Methotrexate—stomach cancer	0.000255	0.000504	CcSEcCtD
Dantrolene—Headache—Methotrexate—stomach cancer	0.000253	0.000501	CcSEcCtD
Dantrolene—Asthenia—Doxorubicin—stomach cancer	0.000251	0.000497	CcSEcCtD
Dantrolene—Dizziness—Epirubicin—stomach cancer	0.00025	0.000495	CcSEcCtD
Dantrolene—Pruritus—Doxorubicin—stomach cancer	0.000248	0.00049	CcSEcCtD
Dantrolene—Vomiting—Epirubicin—stomach cancer	0.000241	0.000476	CcSEcCtD
Dantrolene—Nausea—Methotrexate—stomach cancer	0.00024	0.000475	CcSEcCtD
Dantrolene—Diarrhoea—Doxorubicin—stomach cancer	0.00024	0.000474	CcSEcCtD
Dantrolene—Rash—Epirubicin—stomach cancer	0.000239	0.000472	CcSEcCtD
Dantrolene—Dermatitis—Epirubicin—stomach cancer	0.000238	0.000471	CcSEcCtD
Dantrolene—Headache—Epirubicin—stomach cancer	0.000237	0.000469	CcSEcCtD
Dantrolene—Dizziness—Doxorubicin—stomach cancer	0.000232	0.000458	CcSEcCtD
Dantrolene—Nausea—Epirubicin—stomach cancer	0.000225	0.000444	CcSEcCtD
Dantrolene—Vomiting—Doxorubicin—stomach cancer	0.000223	0.00044	CcSEcCtD
Dantrolene—Rash—Doxorubicin—stomach cancer	0.000221	0.000437	CcSEcCtD
Dantrolene—Dermatitis—Doxorubicin—stomach cancer	0.000221	0.000436	CcSEcCtD
Dantrolene—Headache—Doxorubicin—stomach cancer	0.000219	0.000434	CcSEcCtD
Dantrolene—Nausea—Doxorubicin—stomach cancer	0.000208	0.000411	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—GSTT1—stomach cancer	0.000156	0.000947	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	0.000155	0.000936	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	0.000148	0.000898	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—GSTP1—stomach cancer	0.000108	0.000656	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	0.000107	0.000647	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—GSTM1—stomach cancer	9.96e-05	0.000603	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	9.82e-05	0.000595	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ACAD8—stomach cancer	9.32e-05	0.000564	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GMPR2—stomach cancer	8.3e-05	0.000503	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SUCLG1—stomach cancer	7.6e-05	0.00046	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—IDH3B—stomach cancer	7.6e-05	0.00046	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NDUFS1—stomach cancer	7.06e-05	0.000428	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NDUFV1—stomach cancer	7.06e-05	0.000428	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—BLVRB—stomach cancer	6.29e-05	0.000381	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PGLS—stomach cancer	6.29e-05	0.000381	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPAP2A—stomach cancer	6e-05	0.000364	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—FBP1—stomach cancer	5.35e-05	0.000324	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NDUFA2—stomach cancer	5.35e-05	0.000324	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CKB—stomach cancer	5.35e-05	0.000324	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CA1—stomach cancer	5.35e-05	0.000324	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PLIN2—stomach cancer	5.03e-05	0.000305	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CA2—stomach cancer	4.89e-05	0.000296	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PGAM1—stomach cancer	4.77e-05	0.000289	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NT5E—stomach cancer	4.77e-05	0.000289	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PLCE1—stomach cancer	4.55e-05	0.000276	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALDH7A1—stomach cancer	4.55e-05	0.000276	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—UMPS—stomach cancer	4.36e-05	0.000264	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PDHA1—stomach cancer	4.06e-05	0.000246	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ECHS1—stomach cancer	4.06e-05	0.000246	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—FADS1—stomach cancer	3.81e-05	0.000231	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—TYMP—stomach cancer	3.81e-05	0.000231	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SREBF2—stomach cancer	3.57e-05	0.000216	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—RORA—stomach cancer	3.53e-05	0.000214	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALDOB—stomach cancer	3.31e-05	0.0002	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALOX5—stomach cancer	3.07e-05	0.000186	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—DPYD—stomach cancer	3.02e-05	0.000183	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTT1—stomach cancer	2.67e-05	0.000162	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP2A6—stomach cancer	2.64e-05	0.00016	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AKR1C3—stomach cancer	2.57e-05	0.000156	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ENO1—stomach cancer	2.51e-05	0.000152	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CD44—stomach cancer	2.22e-05	0.000135	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.89e-05	0.000114	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTP1—stomach cancer	1.85e-05	0.000112	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HMOX1—stomach cancer	1.83e-05	0.000111	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—TYMS—stomach cancer	1.72e-05	0.000104	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTM1—stomach cancer	1.7e-05	0.000103	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ERCC2—stomach cancer	1.6e-05	9.7e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—MTHFR—stomach cancer	1.51e-05	9.11e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CAV1—stomach cancer	1.39e-05	8.41e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—APOA1—stomach cancer	1.39e-05	8.39e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPARG—stomach cancer	1.22e-05	7.39e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALB—stomach cancer	1.1e-05	6.65e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NOS3—stomach cancer	1.05e-05	6.36e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PTGS2—stomach cancer	9.6e-06	5.81e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PIK3CA—stomach cancer	5.91e-06	3.58e-05	CbGpPWpGaD
